For example, Yang et al. conjugated iron oxide nanoparticles to ATF (ATF-IO) for delivery to breast cancer cells expressing uPAR and further suggested that ATF-IO nanoparticles can be potentially used as molecularly targeted, dual-modality imaging agents (262). This evidence concerns the gene PLAUR and breast carcinoma.